StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK stock opened at $6.24 on Monday. Merrimack Pharmaceuticals has a 12 month low of $3.66 and a 12 month high of $7.97. The […]
Merrimack Pharmaceuticals (NASDAQ:MACK) Shares Pass Above 200 Day Moving Average of $4 60 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.